1
Department of Radiation Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, United States
2
Cancer Biology Program, University of Michigan, Ann Arbor, MI, United States
3
Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy
4
MitoCare Center, Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA, United States
5
Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, London, United Kingdom
6
Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉*Correspondence: Marco Tigano, Marco.Tigano@jefferson.edu; Rachel Evans, Rachel.evans2@astrazeneca.com; Meredith A. Morgan, mmccrack@med.umich.edu; Qiang Zhang, qiangz@med.umich.edu
Copyright © 2024 Valvo, Vitale, Tigano, Evans, Morgan and Zhang
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.